Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-122493
Filing Date
2024-11-07
Accepted
2024-11-06 17:33:51
Documents
95
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q celu-20240630.htm   iXBRL 10-Q 3194597
2 EX-31.1 celu-ex31_1.htm EX-31.1 16755
3 EX-31.2 celu-ex31_2.htm EX-31.2 16739
4 EX-32.1 celu-ex32_1.htm EX-32.1 10922
5 EX-32.2 celu-ex32_2.htm EX-32.2 10658
  Complete submission text file 0000950170-24-122493.txt   16071514

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT celu-20240630.xsd EX-101.SCH 2505650
98 EXTRACTED XBRL INSTANCE DOCUMENT celu-20240630_htm.xml XML 3182533
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38914 | Film No.: 241432368
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)